The Lancet. Gastroenterology & Hepatology BASE-Bielefeld Academic Search Engine Domingo, E, Camps, C, Kaisaki, P J, Parsons, M J, Mouradov, D, Pentony, M M, Makino, S, Palmieri, M, Ward, R L, Hawkins, N J, Gibbs, P, Askautrud, H, Oukrif, D, Wang, H, Wood, J, Tomlinson, E, Bark, Y, Kaur, K, Johnstone, E C, Palles, C, Church, D N, Novelli, M, Danielsen, H E, Sherlock, J, Kerr, D, Kerr, R, Sieber, O, Taylor, J C & Tomlinson, I 2018, ' Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series ', Lancet Gastroenterology and Hepatology, vol. 3, no. 9, pp. 635-643 . https://doi.org/10.1016/S2468-1253(18)30117-1